Original Research

PLNR≤20% may be a benefit from PORT for patients with IIIA-N2 NSCLC: a large population-based study

Shang X, Li Z, Lin J, Wang H, Wang Z

Cancer Management and Research 2018, 10:3561-3567

Published Date: 17 September 2018